This study underscores the pivotal role of the Ki-67 proliferation index in predicting metastatic disease at the time of adrenocortical carcinoma (ACC) diagnosis, offering a transformative approach to risk stratification through the integration of statistical and machine learning methodologies. Here, MKI67 is linked to adrenal cortex carcinoma.